Medexus Pharmaceuticals Inc.
MEDXF
$1.77
-$0.01-0.56%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.44M | 6.97M | 8.45M | 5.26M | 8.21M |
| Total Receivables | 14.14M | 13.05M | 13.25M | 24.03M | 22.23M |
| Inventory | 34.00M | 38.17M | 36.26M | 30.77M | 27.46M |
| Prepaid Expenses | 9.77M | 5.62M | 7.10M | 10.14M | 13.83M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 369.00K | 388.00K | 388.00K | 2.30M | 2.35M |
| Total Current Assets | 66.72M | 64.20M | 65.45M | 72.50M | 74.08M |
|
|
|||||
| Total Current Assets | 66.72M | 64.20M | 65.45M | 72.50M | 74.08M |
| Net Property, Plant & Equipment | 712.00K | 731.00K | 747.00K | 778.00K | 843.00K |
| Long-term Investments | 9.99M | 10.30M | 10.23M | 10.28M | 10.40M |
| Goodwill | 9.99M | 10.30M | 10.23M | 10.28M | 10.40M |
| Total Other Intangibles | 59.29M | 61.33M | 62.72M | 64.14M | 66.39M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.26M | 8.82M | 8.12M | 8.04M | 8.67M |
| Total Assets | 145.98M | 145.37M | 147.26M | 155.73M | 160.38M |
|
|
|||||
| Total Accounts Payable | 39.75M | 37.12M | 35.44M | 7.75M | 43.35M |
| Total Accrued Expenses | -- | -- | -- | 35.48M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.75M | 17.76M | 16.57M | 15.74M | 15.08M |
| Total Finance Division Other Current Liabilities | 8.85M | 8.57M | 7.22M | 7.25M | 8.05M |
| Total Other Current Liabilities | 8.85M | 8.57M | 7.22M | 7.25M | 8.05M |
| Total Current Liabilities | 66.35M | 63.45M | 59.24M | 66.23M | 66.48M |
|
|
|||||
| Total Current Liabilities | 66.35M | 63.45M | 59.24M | 66.23M | 66.48M |
| Long-Term Debt | 21.74M | 24.74M | 29.77M | 33.80M | 36.62M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 430.00K | 478.00K | 495.00K | 354.00K | 586.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 24.36M | 23.96M | 25.18M | 25.03M | 27.13M |
| Total Liabilities | 112.88M | 112.63M | 114.68M | 125.41M | 130.82M |
|
|
|||||
| Common Stock & APIC | 88.69M | 88.68M | 88.76M | 88.40M | 88.27M |
| Retained Earnings | -61.44M | -62.18M | -62.29M | -64.24M | -65.00M |
| Treasury Stock & Other | 5.85M | 6.23M | 6.12M | 6.17M | 6.30M |
| Total Common Equity | 33.10M | 32.74M | 32.59M | 30.32M | 29.56M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 33.10M | 32.74M | 32.59M | 30.32M | 29.56M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 33.10M | 32.74M | 32.59M | 30.32M | 29.56M |
|
|
|||||